Altimmune inc

Major-Pharmaceuticals

ALT


910 Clopper Road
Gaithersburg , MD 20878

Executive/
Director

Price

  • Last Close
  • $ 7.28
    $ +0.16 2.25 %
    Jan 3, 2025
  • 52-Week High/Low
  • $13.81 - $2.14
  • YTD
  • 0%

  • Trading Volume
  • 92,941
  • Market Cap Full
  • $ 391.1M
  • Shares Outstanding
  • 53.7M
    Nov 3, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 - -41.7% 40.8% -5% 25.9% -33.5% -74.4% -9.2% 0.8% -
Q2 -59.5% -62.6% -27.4% 4% -30.3% 92.1% -16.4% -36.6% - -
Q3 -27.5% -64.2% -19.3% 8% 14.8% 9.2% -26.4% 3.9% - -
Q4 -15% -58.6% -6.9% -15% -19% 28.8% 342.9% -3.1% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 0.8% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    0%0%-97%-11%515%-18%80%-32%-36%1%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 0.03 -7.58 -0.27 - - - -0.40
Q2 0.26 -10.3 -0.26 - - - -0.32
Q3 0.34 -1.73 -0.74 - - - -0.39
Q4 0.12 4.45 -1.6 -1.91 -2.35 -0.47 -
A 0.8 -15.2 -2.9 -1.9 -2.4 -1.8 -1.11

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 13.5 15.4 37.2 43.2 49.3
Jun 25.8 13.5 15.5 38.4 43.2 49.3
Sep 38.5 15.3 32.9 39.7 48.5 52.7
Dec 8.8 15.3 33.1 39.7 49.2 53.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 2 8 6 10
Total Asset Turnover - - - 0.1 0.2
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 29.3 - 9.2 - 10.8
Equity multiplier - - - - -